New cancer drug enters first human trials for Tough-to-Treat tumors
Disease control
Recruiting now
This is the first study in people to test a new drug called PQ203 for advanced solid tumors, including a hard-to-treat type of breast cancer. The main goals are to check if the drug is safe and to find the best dose for future studies. About 80 adults who have run out of standard…
Phase: PHASE1 • Sponsor: ProteinQure Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC